This paper identifies and analyzes the existing frameworks for supporting the identification and classification of best practices at an organization level. The major contribution of this paper is the proposition and application of three criteria for analyzing, comparing and classifying the four identified frameworks. The first criterion is based on structural complexity, facilitates defining the scope of initiatives to identify best practices. The second one, based on the framework orientation, permits choosing a framework depending of the type of studied processes. While the third criterion based on organizational levels, permits comparing and classifying the frameworks in terms of the strategic, tactic or operational issues. In conclusion are outlined important aspects in the selection of a framework according to two proposed scenarios: the best practices searching on Organizations of Excellence and the best practices searching on organizations with a similar business model.

No abstract

Background: Cannabis is the most widely used illicit drug worldwide. Although cannabis can be considered a malignant drug that affects health and produces adverse effects on individuals, their families and society, it should be noted that therapeutic use has a scientific basis. Objective: This study was carried out through a joint methodology that included both the analysis of patents and scientometrics, with the purpose of constructing a profile for the scientific, inventive and innovative activity of marijuana in medical uses. Methodology: The analyses included indicators based on information about the publication and registration of scientific articles and patents, as well as impact indicators measured by the citations of the related publications, facilitating the establishment and understanding of the trends that were identified. Results: As a result, it was intended to establish the state of the technologies, processes and research of this subject to determine whether it is in a state of growth maturity or decline. Additionally, ideas for novel studies are proposed, and information about countries, offices, authors and reference journals is shown to serve as a base for innovators, entrepreneurs and new researchers. Conclusion: The main contribution of this article is the identification of companies and leading applicants in the medical use of cannabis, mainly in the formulation of medical preparations, treatments using these preparations, and heterocyclic compounds present in the Cannabis Sativa plant. Also, potential markets for the protection of inventions in the field are presented, and a review of outstanding articles and patents that can be used to know in depth the interests of the main applicants.

No abstract

No abstract